AUTHOR=Llop Elba , Perelló Christie , Fontanilla Teresa , de la Revilla Juan , Conde Marta Hernández , López Marta , Minaya Javier , Ferre Carlos , Abad Javier , Carrillo Carlos Fernández , Martínez José Luís , Puga Natalia Fernández , Trapero María , Hajra Ismael El , Santos Elena , Calleja José Luis 

TITLE=Spleen Transient Elastography and Damping Index Identify a Subgroup of Patients Without an Acute or Chronic Response to Beta-Blockers

JOURNAL=Frontiers in Medicine

VOLUME=9

YEAR=2022

URL=https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2022.900073

DOI=10.3389/fmed.2022.900073

ISSN=2296-858X

ABSTRACT=<sec><title>Background and Aims</title><p>Monitoring of acute or chronic response to beta-blockers in patients with liver cirrhosis is based on the measurement of the HVPG. Our aim was to evaluate the response to beta-blockers with non-invasive techniques.</p></sec><sec><title>Patients and Methods</title><p>This is a prospective observational study. Consecutive patients with an indication of primary or secondary prophylaxis of variceal bleeding who did not meet exclusion criteria were included. Acute response and chronic response were evaluated. Baseline and after acute and chronic response hepatosplenic measurements of TE and ARFI were obtained. Contrast-enhanced Doppler ultrasound was performed before and after acute and chronic responses.</p></sec><sec><title>Results</title><p>From June 2015 to May 2018, 55 patients (14 with exclusion criteria) were included. We analyzed 41 patients, mean age 57 (<italic>SD</italic>: 8), 82.9% men, alcohol 43.9%, children A/B/C 78%/17.1%/4.9%, and 87.8% on primary prophylaxis. In all, the acute response was performed and was positive in 68.3% (CI 95: 55–85%). The chronic response was performed in 30 (73.2%) and was positive in 36.7% (CI 95: 18–55%). Basal measurements significantly related to acute response were spleen TE [responders 58.4 (<italic>SD</italic>: 23.0) KPa vs. non-responders 75 (<italic>SD</italic>: 0) KPa; <italic>p</italic> = 0.02] and damping index [non-responders 0.96 (0.8) vs. responders 0.44 (0.4), <italic>p</italic> = 0.01], and with chronic response, the spleen TE [responders 58.1 (<italic>SD</italic>: 21.4) KPa vs. non-responders 73.2 (<italic>SD</italic>: 5.5) KPa; <italic>p</italic> = 0.02], and damping index [non-chronic responders 0.8 (0.7) vs. chronic responders 0.4 (0.4), <italic>p</italic> = 0.04]. A spleen TE ≥ 74 KPa had a high sensitivity of 100% and specificity of 60% and a high NPV100% for predicting poor acute response to beta-blockers. The damping index &gt; 0.6 showed moderate sensitivity of 67% and specificity of 69% with a high NPV of 82% for predicting poor acute response to beta-blockers. The combination of both measurements for predicting poor acute response to beta-blockers had an AUC of 0.8 (CI 95: 0.5–0.9). A spleen TE ≥ 74 KPa had a high sensitivity of 87% and specificity of 71% with a high NPV of 71% for predicting poor chronic response to beta-blockers. A damping index &gt; 0.6 had moderate sensitivity of 60%, specificity of 82%, and NPV of 56% for predicting poor chronic response to beta-blockers. The combination of both measurements for predicting poor chronic response to beta-blockers had an AUC of 0.8 (CI 95: 0.7–0.9).</p></sec><sec><title>Conclusion</title><p>Spleen TE and damping index can identify a subgroup of patients with poor acute or chronic response to beta-blockers.</p></sec>